1. Home
  2. CELU vs BTM Comparison

CELU vs BTM Comparison

Compare CELU & BTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • BTM
  • Stock Information
  • Founded
  • CELU 2016
  • BTM 2016
  • Country
  • CELU United States
  • BTM United States
  • Employees
  • CELU N/A
  • BTM N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • BTM Finance: Consumer Services
  • Sector
  • CELU Health Care
  • BTM Finance
  • Exchange
  • CELU Nasdaq
  • BTM Nasdaq
  • Market Cap
  • CELU 40.9M
  • BTM 35.7M
  • IPO Year
  • CELU N/A
  • BTM N/A
  • Fundamental
  • Price
  • CELU $2.46
  • BTM $2.00
  • Analyst Decision
  • CELU
  • BTM Strong Buy
  • Analyst Count
  • CELU 0
  • BTM 3
  • Target Price
  • CELU N/A
  • BTM $3.67
  • AVG Volume (30 Days)
  • CELU 3.1M
  • BTM 2.6M
  • Earning Date
  • CELU 11-07-2024
  • BTM 11-13-2024
  • Dividend Yield
  • CELU N/A
  • BTM N/A
  • EPS Growth
  • CELU N/A
  • BTM N/A
  • EPS
  • CELU N/A
  • BTM N/A
  • Revenue
  • CELU $42,690,000.00
  • BTM $585,282,000.00
  • Revenue This Year
  • CELU N/A
  • BTM N/A
  • Revenue Next Year
  • CELU $233.89
  • BTM $14.52
  • P/E Ratio
  • CELU N/A
  • BTM N/A
  • Revenue Growth
  • CELU 182.02
  • BTM N/A
  • 52 Week Low
  • CELU $1.30
  • BTM $1.33
  • 52 Week High
  • CELU $7.97
  • BTM $3.70
  • Technical
  • Relative Strength Index (RSI)
  • CELU 49.49
  • BTM 55.80
  • Support Level
  • CELU $3.26
  • BTM $1.45
  • Resistance Level
  • CELU $4.34
  • BTM $3.52
  • Average True Range (ATR)
  • CELU 0.84
  • BTM 0.37
  • MACD
  • CELU 0.11
  • BTM 0.08
  • Stochastic Oscillator
  • CELU 29.59
  • BTM 27.96

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About BTM Bitcoin Depot Inc.

Bitcoin Depot Inc owns and operates the largest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.

Share on Social Networks: